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Abstract
Induction and branching morphogenesis of the prostate are dependent on androgens, which act via the mesenchyme to induce prostatic
epithelial development. One mechanism by which the mesenchyme may regulate the epithelium is through secreted growth factors such as
FGF-10. We have examined the male reproductive tract of FGF-10/ mice, and at birth, most of the male secondary sex organs were absent
or atrophic, including the prostate, seminal vesicle, bulbourethral gland, and caudal ductus deferens. Rudimentary prostatic buds were
occasionally observed in the prostatic anlagen, the urogenital sinus (UGS) of FGF-10/ mice. FGF-10/ testes produced sufficient
androgens to induce prostatic development in control UGS organ cultures. Prostatic rudiments from FGF-10/ mice transplanted into intact
male hosts grew very little, but showed some signs of prostatic differentiation. In cultures of UGS, the FGF-10 null phenotype was partially
reversed by the addition of FGF-10 and testosterone, resulting in the formation of prostatic buds. FGF-10 alone did not stimulate prostatic
bud formation in control or FGF-10/ UGS. Thus, FGF-10 appears to act as a growth factor which is required for development of the
prostate and several other accessory sex organs.
© 2003 Elsevier Inc. All rights reserved.
Introduction
The prostate is a branched ductal gland whose mesen-
chymal–epithelial interactions are under the control of sys-
temic androgens (Cunha et al., 1987). In embryonic and
neonatal development, androgens act indirectly via mesen-
chymal androgen receptors to regulate epithelial prolifera-
tion, budding, ductal branching, and apoptosis (Cunha et al.,
1987; Kurita et al., 2001). The paracrine mediators of an-
drogen action have not been conclusively identified, but
FGFs are promising candidates (Lu et al., 1999; Thomson,
2001; Thomson and Cunha, 1999).
The fibroblast growth factors (FGF) constitute a family
of heparin-binding growth signals that play key roles in
organogenesis (Hogan, 1999; Szebenyi and Fallon, 1999).
There are at least 22 FGF ligands (reviewed in Szebenyi and
Fallon, 1999). These ligands each interact with a subset of
FGF receptors. There are 4 genes coding for FGF receptors,
each of which have multiple splice variants (reviewed in
McKeehan et al., 1998). The FGF receptors are dimeric
tyrosine kinase receptors that signal through the ras/raf/
MAPK pathway as well as via PLC/DAG and Ca2 re-
lease (Szebenyi and Fallon, 1999). The cellular effects of
FGFs include survival, proliferation, chemotaxis, differen-
tiation, and regulation of other growth factors and nuclear
factors (reviewed in Szebenyi and Fallon, 1999). Some FGF
family members are expressed at high levels in male repro-
ductive tract organs during embryonic and neonatal stages
and subsequently decline (Thomson and Cunha, 1999;
Thomson et al., 1997).
During organogenesis, several FGF family members play
a significant role in mesenchymal–epithelial interactions.
Fibroblast growth factor-4, FGF-7 (also known as KGF),
and FGF-10 are expressed in the mesenchyme, while their
receptors are predominantly found on adjacent epithelial
cells (Finch et al., 1995; Mason et al., 1994; Orr-Urtreger et
al., 1993). In limb formation, FGF-10 is expressed in a
restricted area of the lateral plate mesoderm. It induces the
differentiation of the apical ectodermal ridge from the sur-
face ectoderm and promotes limb outgrowth (Martin, 2001).
Mechanisms of branching morphogenesis often involve
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FGFs. Lung development in both mice and Drosophila
requires FGF-10 (in Drosophila branchless), which appears
to be a key growth factor and chemotaxic agent (Min et al.,
1998; Park et al., 1998; Peters et al., 1994; Sekine et al.,
1999; Sutherland et al., 1996). FGF-10 is also involved
during development in other organs that undergo branching
morphogenesis, such as the lacrimal gland (Govindarajan et
al., 2000) and pancreas (Bhushan et al., 2001).
In the developing prostate and seminal vesicle, messen-
ger RNAs for FGF-7 and FGF-10 are localized in the
mesenchyme (Finch et al., 1995; Thomson and Cunha,
1999). The receptor for FGF-7 and -10 are found in the
epithelium of the urogenital sinus and Wolffian duct (Finch
et al., 1995). Both FGF-7 and FGF-10 can substitute for
testosterone in organ cultures of neonatal rat prostate, sup-
porting extensive epithelial growth and ductal branching
morphogenesis (Sugimura et al., 1996; Thomson and
Cunha, 1999).
Redundancy of FGF-7 signaling appears to operate dur-
ing development. FGF-7/ mice exhibit no obvious abnor-
malities aside from a rough coat (Guo et al., 1996). Even the
lungs, whose branching morphogenesis is affected by
FGF-7 overexpression (Simonet et al., 1995) and FGFR2b
inhibition (Peters et al., 1994), developed normally in FGF-
7/ mice (Guo et al., 1996). No prostatic phenotype or
problems with fertility have been noted in these mice (Guo
et al., 1996). FGF-10/ mice have been created (Min et al.,
1998; Sekine et al., 1999). These mice die at birth and lack
lungs and limbs; they also have abnormalities in skin dif-
ferentiation (Suzuki et al., 2000). The phenotype of the male
reproductive organs of FGF-10/ mice has not been de-
scribed. In this study, the reproductive tracts of FGF-10/
mice have been examined.
Materials and methods
Animals
FGF-10/ breeding pairs were generously provided by
W. Scott Simonet (Amgen, Thousand Oaks, CA). Mice
were mated and FGF-10/ embryos were recognized by
their lack of limbs (Min et al., 1998; Sekine et al., 1999).
Heterozygous mice were identified by PCR of genomic tail
DNA. The primers were: wild-type 5-CAT TGT GCC TCA
GCC TTT CCC, shared 5-ACT CTT TGG CCT CTA TCT
AG, null 5-CAC CAA AGA ACG GAG CCG GTT G. For
timed pregnant matings, the plug date is day zero. CD1
Nu/Nu (nude) male mouse hosts for grafting were obtained
from Charles River (Wilmington, MA).
Dissection and photography
Organ rudiments were dissected from fetuses and photo-
graphed with a Dage MTI DC330 digital camera (Michigan
City, IN) mounted on a compound or dissecting microscope.
Testes from embryos at 15-16 days postconception (dpc,
also known as E15–E16) and urogenital sinuses (UGSs) that
had been cultured were fixed and photographed to estimate
organ size, as these organs were too small for wet weight
measurement. Organ area was calculated by using the public
domain program, NIH Image (developed at U.S. NIH and
available on the internet at http://rsb.info.nih.gov/nih-image/).
Adobe Photoshop (Mountain View, CA) software was used
to acquire and process images. Statistical differences be-
tween two groups were calculated by using the Student’s t
test, and differences among several groups were calculated
by using an analysis of variance followed by a Fisher’s
PLSD test.
Tissue recombination and grafting
To compare the androgenic ability of control and FGF-
10/ fetal testes, these rudiments were grafted under the
kidney capsule of castrated adult nude mouse hosts. Mice
were anesthetized with avertin (Jones and Krohn, 1960) and
castrated via the scrotal route. Following at least 2 weeks to
allow for full prostatic regression, fetal testes were grafted
(2 per host mouse) under the kidney capsule (Cunha and
Donjacour, 1987). One month after grafting, the hosts were
euthanized, and their prostatic lobes and seminal vesicles
were weighed and examined histologically for evidence of
androgen action. To examine the developmental potential of
the male accessory sex organs from FGF-10 null mice, ages
15 dpc to birth, embryonic rudiments, i.e., the UGS, Wolf-
fian duct (WD), and caudal pelvic urethra (precursor region
for the bulbourethral gland), were grafted under the renal
capsules of adult, intact male nude mice (Cunha and Don-
jacour, 1987). This allows organ growth and development in
the presence of adult levels of testosterone over an extended
time. Some UGSs were harvested 2 weeks after grafting to
assess proliferation and apoptosis, while the rudiments were
actively growing. Grafted organ rudiments were also recov-
ered following 1 month of grafting to evaluate differentia-
tion and organ wet weight.
Tissue recombinants were made by using urogenital si-
nus mesenchyme (UGM) and urogenital sinus epithelium
(UGE) or embryonic bladder epithelium (BLE) from control
(wild-type or heterozygous) and FGF-10 null mice as pre-
viously described (Cunha and Donjacour, 1987). UGM and
UGE from both male mice (15-16.5 dpc) and female mice
(15-19 dpc) were used. Tissue recombinants were harvested
1 month after grafting, weighed, and examined histologi-
cally.
Histology
Fetal organs and grafts were fixed by immersion for 1-2
h at room temperature in neutral buffered formalin. For
paraffin sections, tissues were dehydrated, cleared in Histo-
clear (National Diagnostics, Atlanta, GA), and embedded.
Tissues were cut 6 m in thickness. For plastic sections,
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Fig. 1. Whole-mount (A, B, E, F) and histology (C, D) of male reproductive tracts from control (A, C, E) and FGF-10/ (B, D, F) embryos. (A) At 19 dpc
in control males, both the dorsal (DLP) and ventral (VP) prostatic buds were visible budding from the urogenital sinus (#), distal to the bladder neck (*),
and proximal to the urethra (UR). The seminal vesicles (SV) were visible to either side of the ductus deferens (DD). (B) In FGF-10/ males, the urogenital
sinus (#) and urethra (UR) were visible distal to the bladder neck (*), but prostatic buds were not discernable. In some embryos, the ductus deferens (DD)
remained. (C) The control UGS at 18.5 dpc stained with anti-p63 anti-body (brown), which stains basal epithelial cells, and hematoxylin. Prostatic buds were
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formalin-fixed tissues were dehydrated to 95% ethanol and
embedded in JB-4 plastic (Polysciences, Warrington, PA),
sectioned at 3 m, and stained with methylene blue.
Immunocytochemistry
Prostatic and seminal vesicle secretory proteins were
detected in sections by using rabbit polyclonal antibodies to
mouse dorsolateral prostate, ventral prostate, and seminal
vesicle as previously described (Donjacour et al., 1990;
Higgins et al., 1989). To visualize nuclear markers, i.e.,
androgen receptors, Ki67, and p63, sections were deparaf-
finized and rehydrated; antigens were unmasked by boiling
sections in citrate buffer, pH 6, (Antigen Unmasking solu-
tion; Vector Laboratories Burlingame, CA) for 30 min in a
microwave oven. Blocking solution (Superblock; Pierce,
Rockford, IL) was applied to sections followed by the pri-
mary antibody (anti-androgen receptor,1:50; Affinity Biore-
agents, Golden, CO; anti-p63 antiserum, 1:100; Santa Cruz
Biotechnology, Santa Cruz, CA; or anti-Ki67, 1:200; No-
vocast Laboratories, Newcastle, UK). Antibody binding
was detected by using secondary anti-rabbit or anti-mouse
IgG antibodies (Amersham, Piscataway, NJ) and the ABC
peroxidase method (Vector Laboratories).
To assess proliferation, random paraffin sections of UGS
grown for 2 weeks or UGSs dissected directly from 17-19
dpc male embryos were subjected to antigen retrieval and
were stained immunocytochemically with anti-Ki 67
(Gallee et al., 1989). A minimum of 2500 cells (5 separate
fields) from 3-10 organs or grafts were counted to measure
Ki67 labeling index.
Apoptosis was detected with the terminal transferase
reaction by using the ApopTag peroxidase kit (Intergen Co.,
Purchase, NY).
Organ culture
UGSs from male and female fetuses, ages 15-18 dpc,
were cultured on Millicell CM filters (Millipore Corp, Bed-
ford, MA) floating on 1 ml of medium [DMEM H16:Ham’s
F12 (1:1/vol.) supplemented with 10 g/ml insulin, 5 g/ml
transferrin, 100U/ml penicillin,100 g/ml streptomycin,
and 25 g/ml fungizone (UCSF cell culture facility)] (Fos-
ter et al., 1999). Testosterone (108 M; Steraloids, Wilton
NH) and/or human FGF-10 (100 or 200 ng/ml; BioVision
Inc., Mt. View, CA) were added. Male UGSs from 16-day-
old fetuses were cocultured with testes of the same age from
either control or FGF-10 null fetuses. One or two testes and
one UGS were placed in contact on a filter and floated on
serum-free medium lacking testosterone. Medium was
changed every 2 days for 4 days.
Results
Offspring from FGF-10/ matings were examined by
gross dissection from the age of 15 dpc until birth. At all
ages studied, FGF-10/ and FGF-10/ animals were not
different from each other as judged by body weight, crown-
rump length, and organ weights. These observations were in
agreement with Min et al. (1998). For the purposes of this
study, FGF-10/ and FGF-10/ animals were grouped
together and were referred to as “controls.” As previously
described, FGF-10/ mice died at birth and were identifi-
able embryonically by an absence of limbs (Min et al.,
1998; Sekine et al., 1999).
In FGF-10/ mice, the prostate was not visible at the
end of gestation in whole-mount preparations, whereas
prostatic buds were observed in control mice (Fig. 1A and
B). In histologic sections of control urogenital sinuses
(UGSs) and neonatal prostates, the basal lamina and the bud
distribution were difficult to see with routine hematoxylin
and eosin staining. Late gestation UGSs were therefore
stained with other markers to delineate prostatic buds. These
markers included p63, a nuclear protein found in basal cells
of many organs including the prostate (Signoretti et al.,
2000), and androgen receptors. In control UGSs, numerous
prostatic buds were visible (Fig. 1C). In FGF/ UGSs,
however, the epithelial contours were generally smooth.
Occasionally, buds or indentations of the basal lamina were
observed (Fig. 1D).
The seminal vesicles (SV) and bulbourethral glands were
also absent in FGF-10/ embryos (Fig. 1E and F). The
caudal portion of the WD, 25% of the length of the WD
nearest the UGS, was present in FGF-10/ embryos 15
dpc and younger, but by 18 dpc, it was absent in a majority
of the FGF-10/ males. When present, it was much thinner
than in controls. Testes and epididymides were always
present; in animals in which the caudal WD was absent, the
epididymis was cystic (Fig. 1F). The absence or atrophy of
the male secondary sex organs except the epididymis raised
the possibility that testicular function was compromised in
the FGF-10/ mutants.
Testicular size in FGF-10/ males, as estimated by area
in photographs of testes, was not different from that of
controls (data not shown). The histology of the testes from
FGF-10 mice appeared to be normal (Fig. 2A and B). Cystic
epididymides in FGF-10/ mice maintained a columnar
clearly visible (arrowheads). (D) The FGF-10/ UGS, stained as in (C), had a small number of buds (arrowheads) and more subtle indentations of the basal
lamina (arrow). (E) A view of the whole reproductive tract of a control male at 17.5 dpc, dorsal view, revealed the testes (TS), epididymis (ED), SV, and
DD cranial to the urogenital sinus. One of the paired bulbourethral gland (BUG) is indicated at the caudal-most end of the pelvic urethra. (F) The FGF-10/
male reproductive tract had testes of normal size, but the ductus deferens was highly attenuated and the epididymides were cystic. The seminal vesicles and
bulbourethral glands were absent.
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epithelium in the corpus, and the expanded lumen often
contained cellular debris. Numerous apoptotic bodies were
observed in both the epithelium and stroma of FGF-10/
epididymides (Fig. 2C and D).
As fetal tissue and blood were too limited, functional
assays of androgen production were used. Fetal testes were
grafted under the renal capsules of castrated male nude
mouse hosts. One month after grafting control and FGF-10
/ testes were equally effective in stimulating growth of
the host ventral prostate (VP), increasing the wet weight of
the VP 4-fold (control, n  2) and 3.8-fold (FGF-10/, n
 2) compared with that of castrate hosts without testicular
grafts. However, in hosts grafted with FGF-10/ testes, the
dorsolateral prostate (DLP) and coagulating gland (CG)
were only 2.5-fold larger than those of the castrates, while
DLP and CG from hosts grafted with control testes were
3.6- and 4.5-fold larger. FGF-10/ testes appeared to have
appreciable capacity to produce testosterone, though possi-
bly less than that of controls.
Testicular function was also assessed by an in vitro
method. Testes were cocultured with the prostatic precursor,
the UGS, and the SV to determine whether FGF-10/
testes could support development of control male secondary
sex organs. The reciprocal experiment was also performed
in which control testes were cocultured with FGF-10/
UGSs. Tissues were taken at 16 dpc, a time at which control
prostatic buds had not yet emerged from the urogenital sinus
epithelium, and the seminal vesicle epithelium was un-
folded. After 4 days in culture, prostatic buds were visible in
control UGSs cocultured with control testes, and the SV
epithelium developed infoldings (Fig. 3A). Prostatic buds
and SV epithelial infolding were also clearly present in
control UGSs and SVs cocultured with FGF-10/ testes
(Fig. 3B). Conversely, buds did not form in FGF-10/
UGSs, even when they were cocultured with control testes
(Fig. 3C and D). FGF-10/ testes supported in vitro
growth of control UGSs, but FGF-10/ UGSs were unable
to respond to control testes.
To provide a more rigorous test of the ability of the UGS
from FGF-10/ mice to form prostate, FGF-10/ pros-
tatic rudiments were grafted under the renal capsule of
intact adult nude mice. In this environment, the UGS was
exposed to adult levels of androgens for a period of 1
month. Under these circumstances, control UGSs of both
males and females, at all embryonic ages, give rise to
prostatic tissue (Cunha, 1975; Cunha et al., 1980) (Fig. 4A
and C). Urogenital sinuses from the FGF-10/ mice ex-
hibited some growth, but the wet weight of the grafts was
significantly less than the controls (Fig. 5). Grafts of
FGF-10 / urogenital sinuses did not develop branching
ducts, but after 1 month, more closely resembled the orig-
inal UGS at the time of grafting. The host circulation or
kidney parenchyma did not appear to contribute to the
growth of the grafted FGF-10/ UGS. The epithelium was
mostly stratified (Fig. 4B and D). In some places, however,
there were out-pocketings of simple columnar or cuboidal
epithelium. These out-pocketings sometimes contained ma-
terial that stained with anti-serum to mouse DLP secretory
proteins (anti-mDLP). Intracellular staining was also ob-
served (Fig. 4B). Control UGS grafts developed complex
branched ductal networks. Extensive luminal and some in-
tracellular staining with anti-mDLP were seen in control
UGS grafts (Fig. 4A). The majority of epithelial and mes-
enchymal cells in control and FGF-10/ UGS grafts con-
tained androgen receptors, as judged by immunocytochem-
ical staining (Fig. 4C and D).
Proliferation was measured by counting Ki67-labeled
cells in UGSs grafts, 16.5-17.5 dpc at the start, grown for 2
weeks, a time at which the tissue is actively growing (Cunha
et al., 1983). Mesenchymal labeling was equal in the grafts
of control and FGF-10/ UGS (Fig. 6A). However, the
epithelium in control grafts had a significantly higher label-
ing index than that of FGF-10/ grafts (Fig. 6B). In uro-
genital sinuses taken from embryos in the midst of the
budding stage of prostatic growth in vivo (18.5 dpc), the
UGM and UGE from control and FGF-10/ mice labeled
equivalently with Ki67 antibody (Fig. 6C and D). However,
in the control UGS grafts, the prostatic buds had a signifi-
cantly higher proliferation rate (Fig. 6C and D) than UGE
from either control or FGF-10/ mice. Indentations of the
UGE basal lamina were associated with areas that appeared
to contain more proliferating epithelial cells than other parts
of the UGE in FGF-10/ grafts. (Fig. 6D).
Neither apoptotic bodies nor TUNEL staining was ob-
served in the late gestation male UGSs and developing
prostates of control and FGF-10/ mice. Control and FGF-
10/ UGSs grown for 2 weeks had similarly low apoptotic
rates (data not shown).
Control and FGF-10/ UGSs at 15-17.5 dpc were cul-
tured for 4 days in serum-free medium. In the absence of
testosterone, buds did not form in UGSs of any genotype
(data not shown). In the presence of 108 M testosterone,
control UGSs formed ducts; these ducts were generally
unbranched (Fig. 7A). FGF-10/ UGSs did not form buds
or ducts when cultured with testosterone alone (Fig 7B).
FGF-10 alone (100 or 200 ng/ml) never induced budding in
the absence of testosterone in either control or FGF-10/
UGSs (Fig. 7C). FGF-10 alone or in combination with
testosterone did not induce growth in control UGSs in
culture as measured by explant area (Fig. 7D). FGF-10/
UGSs cultured with testosterone plus FGF-10 grew signif-
icantly less than controls; however, these FGF-10/ si-
nuses developed prostatic buds, partially reversing the
FGF-10 null phenotype (Fig. 7F). Control UGSs cultured with
testosterone and FGF-10 seemed to have wider ducts and have
somewhat more branching per duct than those culture with
testosterone alone (T: 0.05  .02 branch-points/duct, n  13;
TFGF-10: 0.10  .02, n  14, P  0.09) (Fig. 7E).
In FGF-10/ fetuses older than 16 dpc, the caudal
portion of the WD, near the UGS, was usually absent or
extremely thin (Fig. 1F). However, in some male FGF-
10/ fetuses, the caudal WD was still present. When this
43A.A. Donjacour et al. / Developmental Biology 261 (2003) 39–54
Fig. 2. Testes and epididymides from control (A, C) and FGF-10/ (B, D) males. JB-4 sections stained with methylene blue. (A) Control testes at 18.5 dpc
had abundant Sertoli cells (small arrows) lining the seminiferous tubules, scattered germ cells (arrowheads), and prominent fetal Leydig cells (large arrows).
(B) FGF-10/ testes at 18.5dpc were very similar to the controls. (C) Body (corpus) of the epididymis from a control male at 16 dpc. (D) Body (corpus)
of the epididymis from a FGF-10/ male at 16 dpc. The distal part of the Wolffian duct from this fetus had degenerated causing the ductus deferens to
become cystic. Note the numerous apoptotic bodies (arrows) and the dead cells in the lumen (*).
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area was grown under the renal capsule, the majority of
grafts of FGF-10/ caudal WD contained stroma alone
(5/8) or tissue that resembled ductus deferens (2/8). In one
of eight grafts of FGF-10/ caudal WD, tissue resembling
immature SV was observed; this tissue stained with anti-
serum to mouse seminal vesicle secretion (Fig. 8B). In
contrast, grafting a comparable area of control WD yielded
either ductus deferens only (1/6), seminal vesicle only (2/6),
or both (3/6) (Fig. 8A). Thus, the caudal WD from the
FGF-10/ mice had a very limited ability to develop into SV.
When the caudal urethral area from control mice was grafted,
bulbourethral gland tissue developed; this did not occur when
FGF-10/ caudal urethral tissue was grafted. Instead, abun-
dant stroma and a tube of stratified epithelium were observed
(Fig. 8C and D). Thus, FGF-10/ caudal urethra did not
produce bulbourethral gland in this graft environment.
Discussion
The male secondary sex organs of FGF-10/ mice were
almost entirely absent at birth, with the epididymis and the
cranial portion of the WD being the only remaining acces-
sory sexual structures. The explanation for this phenotype is
Fig. 3. Coculture of testes (TS) and urogenital sinus (UGS) from control and FGF-10/ males (16 dpc, n  3 per group). (A) Control testes stimulated
prostatic bud (PR) growth from control UGS and infolding of control seminal vesicle (SV) rudiments. (B) FGF-10/ testes also induced prostatic bud (PR)
growth from control UGS and infolding of the SV, though perhaps not to the same extent as normal testes (A). (C) Control testes did not stimulate bud
outgrowth from FGF-10/ UGS. (D) FGF-10/ UGS cultured with FGF-10/ testes showed no ductal outgrowth.
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likely to be twofold. First, testosterone levels appear to be
somewhat reduced in the FGF-10/ males, and testoster-
one is required for development of all male secondary sex
organs. Second, FGF-10 is required within these organs
themselves for their development.
FGF-10/ mice lack a pituitary gland (Ohuchi et al.,
2000), the source of luteinizing hormone (LH). In fetal life,
however, LH does not appear to play a role in stimulating
testosterone production as it does in adults (Jost, 1971;
O’Shaughnessy et al., 1998). When FGF-10/ testes were
grafted under the renal capsule of castrated males, prostatic
wet weights were stimulated significantly although less than
by control testes. Also, FGF-10/ testes stimulated control
UGS and SV development in coculture. Thus, the fetal
FGF-10/ testes produce androgens at levels sufficient to
induce and promote prostatic and SV development.
The absence of the lower WD in FGF-10/ embryos is
difficult to interpret with regard to the relative contributions
of testosterone and FGF-10. In FGF-10/ embryos, the
entire WD was originally present in all of the embryos 15
dpc and younger. The epididymis and cranial ductus defer-
ens persisted through gestation. Thus, the absence of the
caudal WD was due to regression of a preexisting structure.
Complete WD retention requires testosterone at a critical
threshold level. When testosterone levels are reduced, the
WD are known to be only partially retained (Jost, 1971).
Therefore, the absence of the caudal portion of the WD in
FGF-10/ embryos could be due to suboptimal testoster-
one production by the FGF-10/ testes.
Alternatively, the absence of the caudal WD in FGF-
10/ embryos may highlight a key role of FGF-10 as a
mediator of androgen action in WD maintenance. Only one
Fig. 4. Histology and immunocytochemistry of grafted UGS from control (A, C) and FGF-10/ (B, D) males grown in intact hosts for 1 month. (A)
Anti-mDLP-stained section of control UGS (18 dpc at grafting). (B) Anti-mDLP-stained section of FGF-10/ UGS (18 dpc at grafting). A bud is indicated
by an arrow, and stratified epithelium similar to UGE is indicated by an arrowhead. (C) Anti-androgen receptor-stained section of control UGS (16.5 dpc
at grafting). (D) Anti-androgen receptor-stained section of FGF-10/ UGS (17.5 dpc at grafting). A bud is indicated by an arrow, and stratified epithelium
similar to UGE is indicated by an arrowhead.
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of eight grafted WD developed into SV. The seminal vesicle
mesenchyme expresses high levels of FGF-10 (Thomson
and Cunha, 1999), so the seminal vesicle might be expected
to also show an organ-specific defect in the absence of
FGF-10. It is not known whether the caudal WD mesen-
chyme expresses FGF-10. In the caudal WD, as in the
seminal vesicle, testosterone appears to act indirectly via the
mesenchyme (Drews, 2000), and thus a paracrine role for
FGF-10 is possible.
The primary reason for prostatic agenesis in FGF-10/
mice appears to be the absence of FGF-10 rather than
suboptimal testosterone. While UGSs of all embryonic ages
from both male and female control mice develop into ma-
ture prostate when grown for 1 month in intact, adult male
nude mouse hosts (Cunha, 1975; Cunha et al., 1980), UGSs
from FGF-10/ fetuses did not develop into prostate under
these circumstances. This indicates that supplying adult
levels of testosterone cannot reverse the FGF-10/ pheno-
type. Thus, FGF-10 is required for prostatic development.
Prostatic development was partially restored when the FGF-
10/ UGSs were cultured with testosterone plus FGF-10.
The partial nature of this restoration may be due to an
inadequate concentration of FGF-10 in the medium, or that
4 days may not be enough time for the FGF-10/ UGS to
“catch up.” Female UGS in culture require more time in the
presence of testosterone than male UGS to generate buds
(Takeda et al., 1986). When UGSs from older (19.5 dpc)
female rat fetuses are cultured in the presence of androgens,
they generate fewer prostatic buds than do younger UGSs or
male UGSs (Lasnitzki and Mizuno, 1977). In this study,
age-matched UGSs were cultured simultaneously with
FGF-10/ to reduce UGS age as a confounding factor. In
addition, FGF-10 was present in the control UGS but not in
the FGF-10/ UGS prior to culture, which may suggest
that FGF10 plays an early role in patterning prostatic bud-
ding from the UGS.
Is FGF-10 a prostatic inducer? Clearly, FGF-10 is nec-
essary for growth and branching morphogenesis of the pros-
tate gland. However, FGF-10 meets only two of the three
criteria for an inductive signal (Slack, 1993). The first cri-
terion that FGF-10 fulfills is that it is present at the time of
the induction of prostatic buds and is expressed in the
mesenchyme that is known to send the inductive signal.
Secondly, the absence of an inductive signal must result in
the absence of the organ. This was true in the FGF-10/
mice. The final criterion for an inductive signal, which is not
fulfilled by FGF-10 in the prostate, is that the molecule
should be sufficient to induce organ development. FGF-10
was unable to stimulate prostatic budding in urogenital
sinuses in the absence of testosterone. Although FGF-10
does not meet these criteria for an instructive inductor, our
data suggest that it plays a key permissive role in early event
during the induction of the prostate.
The histological appearance of the FGF-10/ urogenital
sinuses is potentially informative with regards to the very
early events of prostatic induction. These early events have
been generally referred to as “bud induction.” In some
developing structures, such as the feather, budding events
are preceded by a placode stage that follows biochemical
commitment but precedes feather budding (Se´ngel, 1976).
In the prostate, no comparable thickening of the epithelium,
or placode stage has been identified. However the structures
formed by indentations of the basal lamina (Figs. 6 and 9)
may represent a kind of prebud stage similar to that seen in
the lung (Miura and Shiota, 2000; Nogawa et al., 1998). The
first event in the morphogenesis of lung epithelium is a
slight clefting of the basal lamina at irregular intervals
(Miura and Shiota, 2000; Nogawa et al., 1998). This pre-
Fig. 5. Grafted FGF-10/ UGS are smaller and less ductal than controls. (A) The mean wet weight (95% confidence intervals) of control vs. FGF-10/
UGS, aged 15-19 dpc, grafted into intact, nude male mouse hosts for 1 month. FGF-10/ UGSs were significantly smaller than controls (P  0.05). (B)
Whole-mount image of a control UGS grafted for 1 month, 18 dpc at the start. The ductal structure of the graft can be seen (arrow). (C) Whole-mount image
of a FGF-10/ UGS, 18 dpc at the start, grafted for 1 month. No ductal structure was apparent.
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cedes differential proliferation (Nogawa et al., 1998). Bud
induction may therefore be thought of as a two-step process,
the first step being the formation of clefts and irregular buds
and the second step being the stabilization and outgrowth of
these transient buds (Fig. 9).
Time-lapse photography of cultured neonatal bulboure-
thral gland (Cunha unpublished observation) suggests that
the early phase of bud formation is also a dynamic process,
with many small incipient buds forming and disappearing.
Only some of these transient buds become stabilized and
continue to grow and contribute to the adult gland. If this is
true in the male UGS, and if FGF-10 is the stabilizing/
growth factor for nascent buds, histological sections of
FGF-10/ UGS would represent a snapshot of an organ
rudiment stuck in that first step of transient bud formation,
which may explain the relative paucity of final buds in the
FGF-10/ UGS (Fig. 9). It is possible that the UGE con-
tains a constitutive pathway for epithelial budding which is
Fig. 6. Proliferation in FGF-10/ and control tissues. (A) Mesenchymal labeling index was not statistically different in control and FGF-10/ UGSs grafted
for 2 weeks (n  3/per group, mean  95% C.I.). (B) Epithelial labeling index was greater (*, P  0.05) in control than in FGF-10/ UGS grafted for
2 weeks (n  10 per group, mean  95% C.I.). (C) In the control UGS (18.5 dpc), the prostatic ducts were heavily labeled by an antibody against Ki67,
indicating a high rate of proliferation (arrows) as compared with the UGE from which they budded. Mesenchymal cells were also proliferating (arrowheads).
(D) In UGS from FGF-10/ fetuses (18.5 dpc), prostatic ducts are not present, but indentations of the basal lamina (arrows) border areas of the UGE that
appear to have more Ki67-labeled cells (*). Mesenchymal labeling was similar to the control (arrowheads). The Wolffian ducts (WD) can be seen joining
the UGS at the top (dorsal) of the panel.
Fig. 7. Organ culture (4 days) of control and FGF-10/ UGS. (A) A control UGS, 15.5 dpc at the start, grown in the presence of testosterone (108 M)
developed prostatic ducts and occasional clefts (arrow). (B) An FGF-10/ UGS, 16.5 dpc at the start, grown in the presence of testosterone did not develop
prostatic ducts (same scale as in A). (C) A control UGS, 15.5 dpc at the start, grown in the presence of 200 ng/ml of FGF-10, but no testosterone, did not
develop prostatic ducts (same scale as in A). (D) Explant growth in organ culture (percent increase in area mean 95% confidence intervals) of control UGS
grown in the presence or absence of testosterone and/or FGF-10. All groups with the same letter designation are statistically the same, while groups with
different letters (three groups, a–c) are statistically different from each other (P  0.05). (E) A control UGS, 15.5 dpc at the start, grown in the presence
of testosterone and FGF-10. Note the wideness of the ducts and several branch points (arrows, same scale as in A). (F) An FGF-10/ UGS, 15.5 dpc at
the start, grown in the presence of testosterone (108 M) and FGF-10 (200 ng/ml). Prostatic buds formed (arrows).
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independent of androgen action. This may explain the ob-
servation of prostate-like buds in female rat embryos,
though prostatic buds in females are observed at low fre-
quency (Timms et al., 1999)
In grafted FGF-10/ UGS, clefts and early buds
formed. Under the influence of continuous adult levels of
testosterone, epithelial cells of these rudimentary structures
expressed androgen receptors and eventually responded to a
differentiation cue, which may be testosterone itself, and
produced prostatic secretory proteins, albeit at low levels.
Therefore, the first step in prostatic development, commit-
ment and transient bud formation, and the last step, secre-
tory cytodifferentiation, appear to occur in the absence of
FGF-10 and the cellular processes that it controls (Fig. 9).
The role of FGF-10 in the growth of established prostatic
ducts has been clearly demonstrated in cultures of neonatal
rat ventral prostate (VP) in which FGF-10 (and FGF-7) are
able to support branching morphogenesis in the absence of
testosterone (Sugimura et al., 1996; Thomson and Cunha,
1999). In these rat VP organ cultures, the original budding
events had occurred prior to culture and initial dichotomous
branching was already underway. This stimulation of con-
tinued ductal growth and branching is essential to the
growth of a normal prostate, but occurs several days after
prostatic bud induction. Bud induction and stimulation of
ductal growth are different events and may be under the
control of different molecules.
Testosterone qualifies as an inductive signal for the pros-
Fig. 8. Histology of grafts of the lower Wo¨lffian ducts (A, B) and lower urethra (C, D) from control (A, C) and FGF-10/ fetuses. (A) Control grafts showed
typical adult SV histology with papillary folds. Anti-androgen receptor immunocytochemistry showed strong staining of the tall columnar epithelial cells.
Staining with anti-mouse SV proteins (inset). (B) This FGF-10/ graft showed histology typical of the immature SV, which had more stroma, lower
columnar epithelium and a smaller lumen than controls. The low columnar cells showed strong staining with anti-androgen receptor antibody (brown).
Staining with anti-mouse SV proteins (inset). (C) Grafts of the control lower urethra developed into bulbourethral gland. The epithelial cells were filled with
mucous (inset). Hematoxylin and eosin stain. (D) Grafts of the FGF-10/ lower urethra were mostly composed of dense stroma; the epithelium was stratified
and resembled urothelium (* and inset). Hematoxylin and eosin stain.
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Fig. 9. Diagram of a model for regulation of the early events in prostatic budding. (A) The UGS prior to testosterone secretion or the female UGS. FGF-10
is produced by mesenchymal cells some distance from the epithelium and presumably has some ability to diffuse toward the epithelium. Mesenchymal cells,
and not epithelial cells, have androgen receptors; FGF-10 production is not dependent on androgens. Epithelial cells, but not mesenchymal cells, have
receptors for FGF-10 (FGFR2IIIb). (B) The proposed prebud or transient bud stage in a normal male. Testosterone acts on the mesenchyme to stimulate
production of an unknown factor. This factor acts on the epithelium or the extracellular matrix/basal lamina to promote epithelial clefting and/or transient
budding. Close to the epithelium FGF-10 does not reach an effective threshold level. (B*) An alternative pathway for androgen action. The black cells
represent a barrier to FGF-10 action. This barrier could be a band of smooth muscle. The function of the unknown, androgen-dependent factor could be to
prevent barrier formation, or to break down a barrier either by acting on the barrier cells or on adjacent cells so that FGF-10 can reach the epithelium at above
threshold levels. (B) The UGS in FGF-10/ males. The unknown mesenchymal factor is produced in response to testosterone and acts on the epithelium,
but buds cannot be stabilized nor promoted and therefore remain in the prebud stage because these latter events are FGF-10-dependent. (C) The
stabilized/growing bud phase. Some buds have reached into the area of mesenchyme where FGF-10 is above the threshold. Therefore, the buds increase their
growth rate and do not collapse back into the UGE. Shh is expressed in the epithelium, and BMP-4 is expressed in the mesenchyme (Lamm et al., 2002).
(C) The UGS in FGF-10/ males grafted for 1 month in an intact male host. Some clefting remains, but there is no ductal growth. The epithelial cells now
express androgen receptors and produce prostatic secretory proteins.
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tate, as it is necessary and sufficient for prostatic develop-
ment and is present at the correct time. As an endocrine
factor, the inductive actions of testosterone and/or its me-
tabolites extend beyond the prostate to all of the secondary
sex organs. The influence of androgens on the epithelium is
indirect (Cunha et al., 1987) acting via signals, “down-
stream inducers” produced by the mesenchyme. FGF-10 is
clearly a mesenchymal signal required for prostatic devel-
opment and growth, but it is not the only one. In addition,
FGF-10 is not directly regulated by testosterone, at least in
the neonatal prostate and SV (Thomson and Cunha, 1999).
Any signal for instructive induction of the prostate must be
directly or indirectly androgen-dependent. It is possible that
FGF10 protein diffusion is regulated by an androgen-sensi-
tive layer of smooth muscle which forms between inductive
UGM and UGE (Fig. 9) (Thomson et al., 2002).
FGF-10 clearly affects epithelial proliferation in the de-
veloping prostate. Urogenital sinus epithelium from both
control and FGF-10/ mice had significantly lower label-
ing indices than the prostatic buds emerging from the UGE.
In grafts, epithelial labeling index was significantly less in
FGF-10/ than in control tissue. In the lung and pancreas,
FGF-10 stimulates epithelial proliferation (Bhushan et al.,
2001; Park et al., 1998). Elongating prostatic buds grow
toward the source of FGF-10, the mesenchymal cells, which
lie peripherally in specialized zones with in the UGM
(Thomson and Cunha, 1999). In rat the FGF-10-producing
cells reside in the ventral mesenchymal pad, which is
readily identifiable in hematoxylin and eosin-stained sec-
tions (Timms et al., 1995). Apoptosis was not affected by
FGF-10. Programmed cell death was uniformly low in both
control and FGF-10/ UGSs and prostatic grafts exam-
ined. FGF-10 has been shown to stimulate cell migration in
the lung (Park et al., 1998). This remains a possibility in the
prostate.
FGF-10 appears to be an essential factor in branching
morphogenesis in several organs; however, its location in
the hierarchy of signals varies. FGF-10 acts as a true induc-
tive signal for both the lacrimal and Harderian glands where
it is both necessary and sufficient for gland induction and
development (Govindarajan et al., 2000). In both the pan-
creas (Bhushan et al., 2001) and lung (Min et al., 1998), the
initial epithelial outgrowths form in the absence of FGF-10
but then do not proliferate or branch. The prostate appeared
to use FGF-10 in a way that was more similar to the lung
and pancreas than the Harderian and lacrimal glands.
FGF-10 is likely to interact with other growth factors
involved in branching morphogenesis as it does in other
organs. Bone morphogenetic proteins (BMPs) are members
of the transforming growth factor superfamily (Wozney et
al., 1988). BMP-4, as demonstrated by immunocytochem-
istry, is localized close to the early prostatic buds in the
UGS (Lamm et al., 2001), while FGF-10 producing mesen-
chymal cells are separated from the epithelium by a gap of
FGF-10 nonexpressing cells (Fig. 9). As branching morpho-
genesis proceeds, BMP-4 becomes concentrated at branch-
points and FGF-10 at ductal tips. These two growth factors
have opposite effects on branching morphogenesis; FGF-10
stimulates ductal growth, while BMP-4 inhibits it. Neither
of these two molecules is androgen-dependent. In the lung
and tooth, FGF-10 and BMP-4 antagonize each other’s
actions and may interact to establish tooth and lung bud
spacing (Weaver et al., 2000). This may occur also in the
prostate, once branching morphogenesis is initiated.
Sonic hedgehog (Shh) is produced by prostatic buds and
urogenital sinus epithelium (Lamm et al., 2002; Podlasek et
al., 1999). Blocking antibodies to Shh inhibit prostatic de-
velopment (Podlasek et al., 1999). Podlasek et al. have
reported that Shh transcript expression was increased in
UGS in response to androgens, concluding that androgen-
induced expression of Shh in the UGS is necessary for
prostatic induction. However, in the UGM, the expression
of BMP4, a putative downstream signaling effector of the
Shh-signaling pathway (Bitgood and McMahon, 1995), is
not dependent on androgens (Lamm et al., 2001). In the
lung, Shh stimulates mesenchymal proliferation and de-
creases levels of FGF-10 (Bellusci et al., 1997a,b). Sonic
hedgehog is present in the UGE at the time of initial pros-
tatic bud formation and could be involved in this process;
however, it is unlikely to be regulated directly by testoster-
one as prostatic budding can occur in the absence of epi-
thelial androgen receptors (Cunha and Chung, 1981; Cunha
and Lung, 1978; Shannon and Cunha, 1984). Thus, an
androgen-dependent mesenchymal factor that initiates bud-
ding remains to be identified. Future approaches are likely
to include microarray searches for novel factors as well as
examining the roles of known growth factors.
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